Detalhe da pesquisa
1.
Blood-Borne RNA Correlates with Disease Activity and IFN-Stimulated Gene Expression in Systemic Lupus Erythematosus.
J Immunol
; 197(7): 2854-63, 2016 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27534558
2.
Evaluation of RNase therapy in systemic lupus erythematosus: a randomised phase 2a clinical trial of RSLV-132.
Lupus Sci Med
; 11(1)2024 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38325898
3.
Pharmacokinetic and pharmacodynamic properties of TRU-015, a CD20-directed small modular immunopharmaceutical protein therapeutic, in patients with rheumatoid arthritis: a Phase I, open-label, dose-escalation clinical study.
Clin Ther
; 30(10): 1806-16, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19014836
4.
Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial.
Arthritis Rheum
; 50(2): 353-63, 2004 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-14872476
5.
Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept.
J Rheumatol
; 31(7): 1356-61, 2004 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15229957
6.
Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations.
Arthritis Rheum
; 48(6): 1493-9, 2003 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12794815
7.
Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial.
Arthritis Rheum
; 48(1): 218-26, 2003 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-12528122